US 11319536
Modulating apolipoprotein (a) expression
granted A61KA61K31/7125A61K9/0019
Quick answer
US patent 11319536 (Modulating apolipoprotein (a) expression) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue May 03 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/7125, A61K9/0019, A61K9/08, A61P